Page 431 - fbkCardioDiabetes_2017

Cardio Diabetes Medicine 2017 407

13. Nyeland M, et al. Evaluation of the effectiveness of Liraglutide and sita-
gliptin in type 2 diabetes: A retrospective study in UK primary care. Int.
J. Clinical Practice 2015;69(3):281-291.
14. Sabale U, Ekman M, Granstrom O, Bergenheim K. Cost Effectiveness of
dapagliflozin (forxiga) added to metformin compared with sulfonylurea
added to metformin in type 2 diabetes in the Nordic countries. Primary
Care Diabetes 2015;9:39-47.
15. Drouin P. Two year efficacy and safety of Diamicron MR in inadequately
controlled patients with type 2 diabetes. J Nutr Health Aging 2001;5.
16. McGavin J, Perry C, Goa K. Gliclazide Modified Release Adis Interna-
tional Limited, Auckland, New Zealand. ADIS New Formulation Profile
2002;62(9):1357- 1364.
17. Wang H, Ni Y, Yang S, Li H, Li X, Feng B. The Effects of Gliclazide,
Metformin, and Acarbose on Body Composition in Patients with New-
ly Diagnosed Type 2 Diabetes Mellitus. Current Therapeutic Research
2013;75:88-92.
18. NICE Internal Clinical Guidelines Team. Type 2 diabetes in adults Type
2 diabetes: management of type 2 diabetes in adults. Available at:
https://www.nice.org.uk/guidance/gid-cgwave0612/resources/type-2-diabe-
tes-draft- guideline2.

Cardio Diabetes Medicine